Tag: Supply chain

According to the National Institute for Health and Care Excellence (NICE), patient safety incidents related to medications are more likely when reconciliation is delayed, highlighting the importance of timely drug administration in acute care settings. Understanding what are critical drugs and why their timely use is non-negotiable is essential for healthcare professionals and patients alike.

According to the World Economic Forum, by 2025, artificial intelligence (AI) is estimated to drive 30% of new drug discoveries, highlighting its pivotal role in reshaping the pharmaceutical landscape. In response to technological innovation and evolving patient needs, understanding what are the trends in pharma industry 2025 is essential for navigating this transformative era.

As of September 2025, the American Society of Health-System Pharmacists (ASHP) reported over 270 active drug shortages, a persistent problem in the US healthcare system. This ongoing crisis leaves many patients wondering: **What drug is currently in shortage in 2025?** and how will it affect my treatment?

According to the American Society of Health-System Pharmacists (ASHP), there were 271 active drug shortages at the end of 2024, continuing a prolonged crisis. Affecting everything from critical cancer treatments to common antibiotics, the situation prompts a crucial question for patients and providers alike: **what drugs are in shortage right now in the USA**?

Before a single pill can be dispensed to a patient, new drugs must undergo a rigorous approval process that can take over a decade to complete. What is the FDA dispensing process is not a single counter procedure, but a comprehensive, multi-layered regulatory framework involving manufacturers, distributors, and licensed pharmacists to ensure public safety.

According to data from IQVIA, the number of prescriptions for popular GLP-1 medications, like Zepbound and Wegovy, quadrupled over two years, creating unprecedented demand. This surge, combined with numerous supply chain and market factors, explains why many patients still find it so hard to get Zepbound at their local pharmacy.

Recent reports indicate a widespread shortage of Isathal, with some UK suppliers not expecting a restock until early 2026 [1.2.4]. For pet owners and veterinarians who rely on this medication, the pressing question is: why is Isathal out of stock?

According to HealthIT.gov, Computerized Provider Order Entry (CPOE) systems are used in most U.S. hospitals today, marking a significant shift from traditional methods. This evolution has created a variety of methods for ordering drugs, each with distinct processes for different healthcare settings and types of medications.

In 2022, an estimated 9.3 million adults in the U.S. needed treatment for opioid use disorder (OUD), yet only a fraction received it [1.8.2]. This makes the current supply crisis critical, leading patients and providers to ask: **why is buprenorphine on backorder?** [1.2.2, 1.8.2]

Recent drug shortage reports from health authorities like Health Canada indicate multiple betahistine products have experienced significant supply disruptions. Patients relying on this medication for conditions like Meniere's disease are facing challenges understanding why there is a shortage of betahistine and what steps they can take to manage their condition.